{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:46:01Z","timestamp":1793724361499,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013511","name":"Silm\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["20\\u2009200\\u2009005"],"award-info":[{"award-number":["20\\u2009200\\u2009005"]}],"id":[{"id":"10.13039\/501100013511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013511","name":"Silm\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["9AC050"],"award-info":[{"award-number":["9AC050"]}],"id":[{"id":"10.13039\/501100013511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013511","name":"Silm\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["MK332"],"award-info":[{"award-number":["MK332"]}],"id":[{"id":"10.13039\/501100013511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.msard.2026.107205","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:05:20Z","timestamp":1776384320000},"page":"107205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comorbidity of uveitis and multiple sclerosis"],"prefix":"10.1016","volume":"110","author":[{"given":"Hanna-Mari","family":"M\u00e4kel\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Kuusisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6067-6972","authenticated-orcid":false,"given":"Sanna","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107205_bib0001","doi-asserted-by":"crossref","first-page":"e909","DOI":"10.1212\/NXI.0000000000000909","article-title":"Intermediate uveitis associated with MS: diagnosis, clinical features, pathogenic mechanisms, and recommendations for management","volume":"8","author":"Abraham","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107205_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105947","article-title":"Multiple sclerosis-associated uveitis in Persian population, a multicenter study","volume":"92","author":"Anvari","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107205_bib0003","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ibneur.2021.08.003","article-title":"The comparative efficacy and safety of anti-CD20 monoclonal antibodies for relapsing-remitting multiple sclerosis: a network meta-analysis","volume":"11","author":"Asha","year":"2021","journal-title":"IBRo Neurosci. Rep."},{"key":"10.1016\/j.msard.2026.107205_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.52.1.179","article-title":"Multiple sclerosis associated with uveitis in two large clinic-based series","volume":"52","author":"Biousse","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107205_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/09273948.2010.519852","article-title":"Etiologies of chronic anterior uveitis at a tertiary referral center over 35 years","volume":"19","author":"Birnbaum","year":"2011","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.msard.2026.107205_bib0006","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/aos.14697","article-title":"Insights into multiple sclerosis-associated uveitis: a scoping review","volume":"99","author":"Casselman","year":"2021","journal-title":"Acta Ophthalmol. (Copenh)"},{"key":"10.1016\/j.msard.2026.107205_bib0007","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s13311-023-01415-y","article-title":"Effectiveness of Ocrelizumab in primary progressive Multiple sclerosis: a multicenter, retrospective, real-world study (OPPORTUNITY)","volume":"20","author":"Chisari","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.msard.2026.107205_bib0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajo.2025.05.008","article-title":"Fern-like retinal vasculopathy in intermediate uveitis: pathogenesis, natural history, and clinical implications","volume":"277","author":"Cicinelli","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0009","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/09273948.2017.1334469","article-title":"Multiple sclerosis-associated uveitis","volume":"25","author":"Cunningham","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.msard.2026.107205_bib0010","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1007\/s12035-019-1630-2","article-title":"Uveitis and multiple sclerosis: potential common causal mutations","volume":"56","author":"de-la-Torre","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.msard.2026.107205_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/565262","article-title":"Gender and uveitis in patients with multiple sclerosis","volume":"2014","author":"Gordon","year":"2014","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0012","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/jnnp.52.12.1360","article-title":"Ocular inflammatory changes in established multiple sclerosis","volume":"52","author":"Graham","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107205_bib0013","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0014","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","article-title":"Uveitis subtypes in a german interdisciplinary uveitis center - analysis of 1916 patients","volume":"36","author":"Jakob","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.msard.2026.107205_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000341735","article-title":"Pattern of uveitis in an Egyptian population with multiple sclerosis: a hospital-based study","volume":"49","author":"Karara","year":"2013","journal-title":"Ophthalmic. Res."},{"key":"10.1016\/j.msard.2026.107205_bib0016","first-page":"1010","article-title":"Uveitis associated with multiple sclerosis: complications and visual prognosis","volume":"7","author":"Kaya","year":"2014","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0017","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1352458507083444","article-title":"Uveitis associated with multiple sclerosis","volume":"14","author":"Le Scanff","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107205_bib0018","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ophtha.2018.10.013","article-title":"Uveitis in patients with multiple sclerosis in clinical trials of Fingolimod","volume":"126","author":"Lim","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2026.107205_bib0019","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jama.2025.4358","article-title":"Uveitis in adults: a review","volume":"334","author":"Maghsoudlou","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.msard.2026.107205_bib0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/01658107.2025.2563194","article-title":"Characterisation of ocular manifestations in patients with multiple sclerosis in Colombia: a multicentric study","volume":"50","author":"Manrique-Samer","year":"2026","journal-title":"Neuro-Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0021","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1177\/1352458511414041","article-title":"Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis","volume":"17","author":"Marrie","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107205_bib0022","article-title":"Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria\u2014a nationwide population-based registry study over five decades","volume":"11","author":"Maunula","year":"2025","journal-title":"Mult. Scler. J. \u2013 Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107205_bib0023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/bjophthalmol-2014-305518","article-title":"Characterisation of uveitis in association with multiple sclerosis","volume":"99","author":"Messenger","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0024","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.survophthal.2016.07.002","article-title":"The association between multiple sclerosis and uveitis","volume":"62","author":"Olsen","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/bjo.56.6.478","article-title":"Uveitis in association with multiple sclerosis","volume":"56","author":"Porter","year":"1972","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0026","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0161-6420(99)90122-7","article-title":"Pars planitis","volume":"106","author":"Raja","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2026.107205_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264918","article-title":"Uveitis prior to clinical presentation of multiple sclerosis (MS) is associated with better MS prognosis","volume":"17","author":"Raskin","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2026.107205_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307455","article-title":"Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: a systematic review and meta-analysis","volume":"19","author":"Saboya-Galindo","year":"2024","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2026.107205_bib0029","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-510X(01)00520-2","article-title":"Patients with multiple sclerosis and concomitant uveitis\/periphlebitis retinae are not distinct from those without intraocular inflammation","volume":"187","author":"Schmidt","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107205_bib0030","doi-asserted-by":"crossref","first-page":"8751","DOI":"10.3390\/ijms25168751","article-title":"Primary progressive multiple sclerosis\u2014a key to understanding and managing disease progression","volume":"25","author":"Sempik","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.msard.2026.107205_bib0031","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1352458514539782","article-title":"Uveitis as a prognostic factor in multiple sclerosis","volume":"21","author":"Shugaiv","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107205_bib0032","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1111\/ene.15453","article-title":"Anti-CD20 therapy for multiple sclerosis-associated uveitis: a case series","volume":"29","author":"Stascheit","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2026.107205_bib0033","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16480","article-title":"Stable excess mortality in a multiple sclerosis cohort diagnosed 1970\u20132010","volume":"31","author":"Sumelahti","year":"2024","journal-title":"Euro J Neurol."},{"key":"10.1016\/j.msard.2026.107205_bib0034","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9394(14)70994-8","article-title":"The association of HLA-DR15 and intermediate uveitis","volume":"123","author":"Tang","year":"1997","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajo.2021.03.044","article-title":"Classification criteria for multiple sclerosis-associated intermediate uveitis","volume":"228","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0036","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107205_bib0037","first-page":"93","article-title":"Retinal periphlebitis in multiple sclerosis: a marker of disease activity?","volume":"33","author":"Tola","year":"1993","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2026.107205_bib0038","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1442-9071.2000.00270.x","article-title":"Symptomatic intraocular inflammation in multiple sclerosis","volume":"28","author":"Towler","year":"2000","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0039","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.survophthal.2024.11.002","article-title":"Uveitis among people with multiple sclerosis: a systematic review and meta-analysis","volume":"70","author":"Vaheb","year":"2025","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.survophthal.2024.11.002","article-title":"Uveitis among people with multiple sclerosis: a systematic review and meta-analysis","volume":"70","author":"Vaheb","year":"2025","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107205_bib0041","first-page":"203","article-title":"The appearance of pars planitis in multiple sclerosis","volume":"29","author":"Vidovi\u0107","year":"2005","journal-title":"Coll. Antropol."},{"key":"10.1016\/j.msard.2026.107205_bib0042","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/jnnp-2023-332573","article-title":"Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study","volume":"95","author":"Zivadinov","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826002415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826002415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:24:19Z","timestamp":1780327459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826002415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"alternative-id":["S2211034826002415"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107205","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidity of uveitis and multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107205"}}